Conference Date & Time:
May 2, 2020 | 8am – 5pm
R.I.S.E. Demonstration Center
2730 Martin Luther King Jr Ave SE, Washington, DC 20032
VIEW THE 2019 CIE GALLERY
VIEW THE 2018 CIE GALLERY
VIEW THE 2017 CIE GALLERY
VIEW THE 2016 CIE GALLERY
VIEW THE 2015 CIE GALLERY
2020: Bridging the Health Equity Gap
CANCELLED DUE TO COVID-19
May 2, 2020 | 8am – 5pm | RISE Center, 2730 Martin Luther King Jr. Ave. SE, Washington, DC 20032
Registration is now closed for the conference.
Importance of Participation
The WHO warns that the cancer burden is getting worse with low income countries being hit the hardest. Currently 70 % of cancer’s 8 million deaths occur in low income countries.
There are projections that without appropriate and aggressive action, within a few years cancer will likely be the dominant health issue in Africa.
Headline data presented at the World Cancer Congress in December 2014 states that “Low-income countries – where services are least developed, facilities largely absent and trained cancer experts few – will need support from the international community to build capacity, a process that is likely to take a decade or more.”
We must position ourselves now to optimize partnerships, take full advantage of the wide resources available and actively explore opportunities for collaborations and capacity building between Africa and the west.
– Shed light on the disparity and the challenges in cancer care in Africans and people of African descent
– Promote collaborations in cancer care, research and education in Africans and people of African descent
– Learn about innovative tools in cancer treatment…Roche
– Highlight collaborative solutions on cancer that are within our reach
– Role of spiritual healing in cancer treatment among Africans and people of African descent
Who Should Attend?
- Oncology Practitioners
- Cancer/health Researchers and Scientists
- NGO and Non-profit Managers
- Health Policymakers
- Frontline Staff in Cancer Care:
(Nurses, Pharmacists, Social Workers, Clinicians, Families and Other Care Givers)
- Other Cancer Care Stakeholders
- The General Public